BC	breast cancer
BCSS	breast cancer specific survival
dNLR	derived neutrophil to lymphocyte ratio
DFS	disease free survival
DSS	disease specific survival
ER	estrogen receptor
ET	endocrine therapy
HR	hazard ratio
LMR	lymphocyte to monocyte ratio
MCH	mean corpuscular hemoglobin
NI	not indicated
NLR	neutrophil to lymphocyte ratio
NMR	neutrophil to monocyte ratio
NSAIDs	non-steroidal anti-inflammatory drugs
OR	Odd ratio
OS	overall survival
PCR	pathological complete response
PLR	platelet to lymphocyte ratio
PR	progesterone receptor
RDW	red cell distribution
RFS	recurrence free survival
TILs	tumor infiltrating lymphocytes
TNBC	triple negative breast cancer